Indeed, SLC44A2 polymorphisms have been identified in genome‐wide association studies to have an allele‐specific association with venous thromboembolism and cardiovascular diseases (Germain et al, 2015; Hinds et al, 2016). Here, SLC44A2 is linked to cardiovascular disorder.